Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors

The Evaluation of Platelet Count as an Indicator of Iron Status in Voluntary Plateletpheresis Donors

An Analysis of Deferral Pattern in Plateletpheresis Donors

Background: Platelet utilization has increased much more than other components worldwide in last 2 decades. Single donor platelets (SDP) have several benefits over random donor platelets, therefore being preferred. However, stringent criteria of donor selection and therefore high rate of deferral are major limitations to availability of SDP. Aim: The present study was carried out to evaluate th...

The significance of evalution of haematocrit in plateletpheresis donors.

BACKGROUND The collection of platelets by apheresis is considered as a very great progress in transfusion medicine. In present era, many automated cell separation are available each model has tried to improve productivity, quality of plateletpheresis. Further various studies have been done to correlate the quality of platelet concentrates. Also, various biochemical studies have been done on pla...

Evaluation of Anti-A and Anti-B Alloisogglutinin Titer in Group O Plateletpheresis Donors

Clinicians and Blood Service Personnel are well acquainted and experienced with RBC transfusions and practice using well established policies and strategies. To date, pre-transfusion compatibility tests performed, in Blood Banks, are still based on the interaction between antigen and antibody and subsequent agglutination of red blood cells. Tests that identify the antibody indicate the probable...

Is There a Problem of Immunodeficiency in Long-Term Plateletpheresis Donors?

In the last few years, recommendations, guidelines, and laws have all served as important motivators, not just for improving the quality of medical products such as blood components but also for carefully and comprehensively guaranteeing the safety of blood donors. The German Guidelines for the Collection of Blood and Blood Components from 2000 [1] allow 26 thrombocytaphereses per year without ...